drugset

drugset / Trial / NCT00145093

Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus

NCT00145093 ↗

Phase 3 Completed 60 enrolled Medical Research Foundation, The Netherlands Pharma Nord · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether chromium (yeast), is effective in improving glycaemic control and insulin resistance.

Timeline

Start: 2004-08
Primary completion: —
Completion: 2005-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Chromium	Small molecule	400 ug	Oral

Indications